Sinco Pharmaceuticals Holdings Ltd. 6833
HKEX · Hong Kong SAR China · Distribution Services
HKD 0.1260-0.01 (-10.00%)
Market open· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
MakklerAI · PRO
MakklerPRO is required for MakklerAI questions and forward scenarios grounded in structured data for the selected stock.
Upgrade to MakklerPROUpgrade to MakklerPRO to see the Makkler Fair Value calculation, the fundamental score and the multiples behind it.
Upgrade to MakklerPROUpgrade to MakklerPRO to see a 1-5 score for profitability, growth, cash-flow quality, and balance-sheet health.
Upgrade to MakklerPROUpgrade to MakklerPRO to see an AI-generated executive summary and bull/bear breakdown built from this stock's financial data.
Upgrade to MakklerPRO| Company | Market cap | P/E | P/B | P/S | Net margin | Revenue growth | Dividend yield | Beta |
|---|---|---|---|---|---|---|---|---|
| 6833Sinco Pharmaceuticals Holdings Ltd. | HKD 284.60M | 8.3 | 0.3 | 0.1 | 1.6% | -20.0% | 1.2% | 0.3 |
| Zhongzheng International Company Limited | HKD 333.82M | — | — | — | -122.8% | -40.0% | 0.0% | 0.4 |
| Kingworld Medicines Group Ltd. | HKD 239.57M | 18.8 | 0.3 | 0.3 | 1.4% | -13.8% | 8.0% | 0.8 |
| Yunnan Energy International Co. Limited | HKD 352.56M | 34.5 | 2.0 | 0.8 | 2.6% | -22.0% | 0.0% | -0.1 |
| Tycoon Group Holdings Limited | HKD 223.50M | 7.2 | 0.4 | 0.2 | 2.8% | 13.8% | 0.0% | -0.3 |
| China Health Group Ltd | HKD 423.08M | — | 7.9 | 10.6 | -116.6% | 5.5% | 0.0% | 0.1 |
| Yestar Healthcare Holdings Co Ltd | HKD 167.73M | — | 0.4 | 0.1 | -6.1% | -28.1% | 0.0% | 1.1 |
| Grand Brilliance Group Holdings Limited | HKD 130.40M | 15.5 | 1.1 | 1.2 | 8.4% | 6.6% | 1.5% | 0.2 |
| ETHK Labs Inc. | HKD 705.35M | — | 0.2 | 0.2 | -2.6% | -2.6% | 0.0% | 0.9 |
| Peer median | 17.1 | 0.4 | 0.3 | -0.6% | -8.2% | 0.0% | 0.3 |
Peers are selected automatically from companies in the same industry. Extreme ratios (a loss-making company's P/E, or one distorted by a one-off item) are not adjusted away, which is why the summary row uses the median rather than the average. Not investment advice. The ratios in this table come from one outside provider for every company, so the comparison is internally consistent; they can differ from the filing-derived ratios higher up the page because the definitions differ.